| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 4e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |